Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases

Area of Science:

• Neuroscience
• Biochemistry
• Gerontology

Background:

• Dementia, including Alzheimer's disease, is a progressive neurodegenerative disorder.
• Glycolytic enzymes are crucial for cellular energy metabolism in the brain.
• Age-related changes in enzyme activity can complicate the study of disease-specific alterations.

Purpose of the Study:

• To investigate alterations in glycolytic enzyme activities in human temporal lobes from patients with various forms of dementia.
• To compare dementia-associated enzyme changes with those observed during normal aging.
• To differentiate the impact of Alzheimer's disease and bronchopneumonia on brain glycolytic enzyme profiles.

Main Methods:

• Analysis of glycolytic enzyme activities in human autoptic temporal lobe tissue.
• Comparison of enzyme activity levels between dementia patients, normal aging individuals, and patients with bronchopneumonia.
• Statistical analysis to identify significant differences and correlations.

Main Results:

• Some glycolytic enzymes (hexokinase, phosphofructokinase, phosphoglycerate mutase) showed intensified activity in dementia, similar to normal aging.
• Other enzymes (aldolase, phosphoglucose isomerase, triosephosphate isomerase, lactate dehydrogenase) exhibited dementia-specific changes not seen in aging.
• Enzyme activity reductions were observed in bronchopneumonia, complicating differentiation from dementia, particularly for triosephosphate isomerase and lactate dehydrogenase.

Conclusions:

• Dementia induces specific alterations in glycolytic enzyme activity in the brain.
• The effects of aging and dementia on certain glycolytic enzymes are additive.
• Distinguishing between dementia and bronchopneumonia based solely on glycolytic enzyme activity in brain tissue is challenging.